首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >In vitro comparison of four cerebral protection filters for preventing human plaque embolization during carotid interventions.
【24h】

In vitro comparison of four cerebral protection filters for preventing human plaque embolization during carotid interventions.

机译:四种脑保护过滤器在颈动脉介入治疗期间预防人斑栓塞的体外比较。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To evaluate in an in vitro bench-top model the efficacy of 4 filtration devices designed for cerebral protection during carotid angioplasty. METHODS: Embolization during carotid angioplasty was simulated with human plaque material (8 to 12 particles weighing 6.02 +/- 0.10 mg) in an open flow model with the aortic arch and carotid bifurcation made from elastic silicone tubes and saline used as the fluid medium. The 500 to 1500-microm particles were injected into the internal carotid artery (ICA) in front of the test protection device, which was deployed 5 cm distal to the bifurcation. Particles getting past the protection device or flowing into the external carotid artery (ECA) were caught in 100-microm filters and weighed. Ten trials were made on each of 4 devices: Angioguard, FilterWire EX, TRAP, and NeuroShield. All were deployed according to the manufacturers' directions except the FilterWire, which was manually repositioned in all tests to eliminate a gap between the filter and the tube wall. RESULTS: The lowest weight of missed particles in the effluent was obtained with the NeuroShield (0.05 +/- 0.04 mg, 0.8% of injected particle weight) and FilterWire (0.08 +/- 0.05 mg, 1.3%; p=0.254 compared to NeuroShield, p=0.006 versus TRAP). The weight of particles missed by the TRAP device (0.16 +/- 0.06 mg, 2.6%; p<0.001 versus NeuroShield and Angioguard, p<0.05 compared to FilterWire) was higher, and the largest amount of missed particles was observed with the Angioguard filter (0.27 +/- 0.06 mg, 4.4%; p<0.001 compared to all). NeuroShield and FilterWire were significantly different (p<0.001) compared to Angioguard and TRAP in a pairwise analysis. No embolization into the ECA occurred. CONCLUSIONS: In vitro, none of the tested devices had the ability to completely prevent embolization into the ICA. Comparing current designs, the NeuroShield filter and the FilterWire EX captured the highest percentage of human particles in this in vitro model, probably due to their larger filter volume.
机译:目的:在体外台式模型中评估为颈动脉血管成形术期间的脑保护设计的4种过滤装置的功效。方法:在开放流模型中,以人类斑块材料(8至12个颗粒,重6.02 +/- 0.10 mg)模拟颈动脉血管成形术期间的栓塞,主动脉弓和颈动脉分叉由弹性硅胶管和生理盐水制成,作为流体介质。将500至1500微米的颗粒注射到测试保护装置前方的颈内动脉(ICA)中,该装置在分叉远端5厘米处展开。通过保护装置或流入颈外动脉(ECA)的颗粒被100微米过滤器捕获并称重。在以下4种设备上分别进行了10次试验:Angioguard,FilterWire EX,TRAP和NeuroShield。除FilterWire以外,所有其他部件均按照制造商的说明进行部署,FilterWire在所有测试中均已手动重新放置,以消除过滤器和管壁之间的间隙。结果:与NeuroShield相比,NeuroShield(0.05 +/- 0.04 mg,0.8%的注入颗粒)和FilterWire(0.08 +/- 0.05 mg,1.3%; p = 0.254)获得了废水中漏出颗粒的最低重量。 ,相对于TRAP,p = 0.006)。 TRAP设备遗漏的颗粒重量更高(0.16 +/- 0.06 mg,2.6%;与NeuroShield和Angioguard相比p <0.001,与FilterWire相比p <0.05),并且使用Angioguard观察到的颗粒遗失量最大过滤器(0.27 +/- 0.06 mg,4.4%;与所有相比p <0.001)。在成对分析中,与Angioguard和TRAP相比,NeuroShield和FilterWire有显着差异(p <0.001)。没有栓塞到ECA中。结论:在体外,没有一种被测试的装置能够完全防止栓塞到ICA中。比较当前的设计,NeuroShield过滤器和FilterWire EX在此体外模型中捕获了最高百分比的人类颗粒,这可能是因为它们的过滤器体积较大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号